ProBio Opens GMP AAV Manufacturing Facility in Hopewell, US to Support Gene Therapy Development
ProBio has launched its cGMP Adeno-Associated Virus (AAV) manufacturing services at its state-of-the-art Hopewell, New Jersey facility, offering fully integrated, end-to-end viral vector production to support the advancement of gene therapies.
ProBio | 12/08/2025 | By Mrinmoy Dey | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy